← Insider Monitor
Clene Inc. logo
CLNN

Clene Inc.

Nasdaq · Pharmaceutical Preparations

2
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Clene Inc. is a clinical-stage biopharmaceutical company developing nanocrystalline gold, platinum, and other metal-based drug candidates to treat neurodegenerative diseases such as ALS and multiple sclerosis.

Industry
Pharmaceutical Preparations
Headquarters
Salt Lake City, UT
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
WILCOX REED NDirectorBuy$27KNov 18, 2026
WILCOX REED NDirectorBuy$7KNov 18, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for CLNN.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable CLNN activity by email

Free alerts for the insider and congressional trades worth watching.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.